Estanislao Nistal-Villán

Has grant

Professor

Universidad CEU San Pablo Facultad de Farmacia

Spain

Research Interests

Explore related searches

Professors in Spain Professors in Immunology Immunology professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Estanislao Nistal-Villán is a Professor at Universidad CEU San Pablo Facultad de Farmacia in Spain. His research primarily focuses on virology, immunology, and the interaction between viral infections and the microbiome, as highlighted in his recent articles. Notable works include studies on influenza vaccine efficacy, immune response mechanisms, and innovative approaches to cancer therapy through engineered non-human RNA viruses.

Recent Grants

Grant: Close

Desarrollo de Nuevos Tratamientos Para la Infección Crónica Por El Virus de la Hepatitis B Basados en la Transferencia de Genes Utilizando Vectores Virales hepatotropos de Larga Expresión

Open Date:

Close Date:

Grant: Close

NEW ADVANCED VACCINES IN CHRONIC HEPATITIS B “NAVICHEB”

Open Date:

Close Date:

Articles (15)

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (17)

Giulia Pasqual

Associate Professor

University of Padova

ITALY

Estanislao Nistal-Villán

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (15)

Gripe aviar: la persistente amenaza de la próxima pandemia

Influenza vaccine outcomes: a meta-analysis revealing morbidity benefits amid low infection prevention

Influenza A virus infection alters the resistance profile of gut microbiota to clinically relevant antibiotics

The Many Ways to Deal with STING

Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis

Immune synapse formation promotes lipid peroxidation and MHC-I upregulation in licensed dendritic cells for efficient priming of CD8+ T cells

Engineering Non-Human RNA Viruses for Cancer Therapy

Targeting Signaling Pathway Downstream of RIG-I/MAVS in the CNS Stimulates Production of Endogenous Type I IFN and Suppresses EAE

Trained immunity induction by the inactivated mucosal vaccine MV130 protects against experimental viral respiratory infections.

Broad virus inactivation using inorganic micro/nano-particulate materials.

Antibacterial Ability of Sodium Hypochlorite Activated with PUI vs. XPF File against Bacteria Growth on Enterococcus faecalis Mature Biofilm

Efficacy of EDTA and HEDP Chelators in the Removal of Mature Biofilm of Enterococcus faecalis by PUI and XPF File Activation

The BCG Vaccine for COVID-19: First Verdict and Future Directions.

Linking the Expression of Therapeutic Genes to Unfolded Protein Response: A New Option for Anti-Hepatitis B Virus Gene Therapy.

African Swine Fever Virus Ubiquitin-Conjugating Enzyme Interacts With Host Translation Machinery to Regulate the Host Protein Synthesis.

Collaborators (17)

Giulia Pasqual

Carlos Maluquer de Motes

Gloria Gonzalez-Aseguinolaza

Ruben Hernandez‐Alcoceba

Beatriz de Pascual-Teresa

Alejandro Alvarez-Sagües

Sara Cuadrado-Castano

Neris Michel Enamorado Escalona

Roberto López-Píriz

Marzia Marciello

Pedro Antonio Jimenez Gómez

Adolfo Garcia-Sastre

Inmaculada Galindo

Claire Coderch

Vicente Soriano

Trevor Owens

Mirco Schmolke

Make your next move.